SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

60 Degrees Pharmaceuticals Plans to Unblind Tafenoquine Study in January 2027

Valid market news retained in the public archive without immediate LiveCast distribution.

SXTP

Related stories